Instil Bio Statistics

Total Valuation

Instil Bio has a market cap or net worth of $134.50 million. The enterprise value is $98.70 million.

Market Cap	134.50M
Enterprise Value	98.70M

Important Dates

The last earnings date was Wednesday, November 13, 2024, before market open.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

Instil Bio has 6.53 million shares outstanding. The number of shares has increased by 0.05% in one year.

Current Share Class	6.53M
Shares Outstanding	6.53M
Shares Change (YoY)	+0.05%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	2.53%
Owned by Institutions (%)	23.17%
Float	2.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	42.06
PB Ratio	0.76
P/TBV Ratio	0.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.90, with a Debt / Equity ratio of 0.48.

Current Ratio	12.90
Quick Ratio	11.78
Debt / Equity	0.48
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.63

Financial Efficiency

Return on equity (ROE) is -36.63% and return on invested capital (ROIC) is -13.06%.

Return on Equity (ROE)	-36.63%
Return on Assets (ROA)	-12.40%
Return on Capital (ROIC)	-13.06%
Revenue Per Employee	n/a
Profits Per Employee	-$1.53M
Employee Count	49
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +186.25% in the last 52 weeks. The beta is 1.61, so Instil Bio's price volatility has been higher than the market average.

Beta (5Y)	1.61
52-Week Price Change	+186.25%
50-Day Moving Average	29.13
200-Day Moving Average	20.97
Relative Strength Index (RSI)	37.54
Average Volume (20 Days)	110,104

Short Selling Information

The latest short interest is 243,787, so 3.74% of the outstanding shares have been sold short.

Short Interest	243,787
Short Previous Month	303,199
Short % of Shares Out	3.74%
Short % of Float	10.20%
Short Ratio (days to cover)	2.29

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-60.82M
Pretax Income	-123.32M
Net Income	-75.17M
EBITDA	-56.91M
EBIT	-60.82M
Earnings Per Share (EPS)	-$11.56

Full Income Statement

Balance Sheet

The company has $121.14 million in cash and $85.35 million in debt, giving a net cash position of $35.80 million or $5.49 per share.

Cash & Cash Equivalents	121.14M
Total Debt	85.35M
Net Cash	35.80M
Net Cash Per Share	$5.49
Equity (Book Value)	176.33M
Book Value Per Share	27.02
Working Capital	122.29M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$58.52 million and capital expenditures -$58,000, giving a free cash flow of -$58.58 million.

Operating Cash Flow	-58.52M
Capital Expenditures	-58,000
Free Cash Flow	-58.58M
FCF Per Share	-$8.98

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Instil Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.05%
Shareholder Yield	-0.05%
Earnings Yield	-55.89%
FCF Yield	-43.55%

Analyst Forecast

The average price target for Instil Bio is $100.33, which is 386.80% higher than the current price. The consensus rating is "Buy".

Price Target	$100.33
Price Target Difference	386.80%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 8, 2023. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Dec 8, 2023
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1